A detailed history of Benjamin Edwards Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Benjamin Edwards Inc holds 59,871 shares of AZN stock, worth $4.07 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
59,871
Previous 13,334 349.01%
Holding current value
$4.07 Million
Previous $1.04 Million 348.56%
% of portfolio
0.07%
Previous 0.2%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $3.57 Million - $4.08 Million
46,537 Added 349.01%
59,871 $4.67 Million
Q2 2024

Aug 12, 2024

SELL
$66.81 - $80.83 $102,486 - $123,993
-1,534 Reduced 10.32%
13,334 $1.04 Million
Q1 2024

Apr 29, 2024

BUY
$61.03 - $69.57 $61 - $69
1 Added 0.01%
14,868 $1.01 Million
Q4 2023

Feb 06, 2024

SELL
$61.89 - $69.28 $418,933 - $468,956
-6,769 Reduced 31.29%
14,867 $1 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $219,517 - $242,704
3,385 Added 18.55%
21,636 $1.47 Million
Q2 2023

Aug 15, 2023

BUY
$69.91 - $75.81 $23,909 - $25,927
342 Added 1.91%
18,251 $1.31 Million
Q1 2023

Apr 27, 2023

SELL
$63.15 - $71.6 $215,025 - $243,797
-3,405 Reduced 15.98%
17,909 $1.24 Million
Q4 2022

Feb 07, 2023

BUY
$54.21 - $70.44 $147,830 - $192,089
2,727 Added 14.67%
21,314 $1.45 Million
Q3 2022

Oct 28, 2022

BUY
$53.02 - $135.75 $98,511 - $252,223
1,858 Added 11.11%
18,587 $1.02 Million
Q2 2022

Aug 12, 2022

BUY
$59.26 - $71.14 $136,535 - $163,906
2,304 Added 15.97%
16,729 $1.11 Million
Q1 2022

May 04, 2022

BUY
$55.72 - $67.12 $354,434 - $426,950
6,361 Added 78.88%
14,425 $957,000
Q4 2021

Feb 07, 2022

BUY
$54.02 - $63.83 $382,785 - $452,299
7,086 Added 724.54%
8,064 $470,000
Q3 2021

Nov 02, 2021

BUY
$55.56 - $60.79 $37,669 - $41,215
678 Added 226.0%
978 $59,000
Q1 2020

May 07, 2020

BUY
$37.79 - $51.33 $11,337 - $15,399
300 New
300 $13,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $211B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.